This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gopichand, I. Articles by Goldfarb, J. Search for Related Content PubMed PubMed Citation Articles by Gopichand, I. Articles by Goldfarb, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB AMOXICILLIN PENICILLIN V PENICILLIN VK Medline Plus Health Information Sore Throat Streptococcal Infections Social Bookmarking                   What's this?

Randomized, Single-Blinded Comparative Study of the Efficacy of Amoxicillin (40 mg/kg/day) Versus Standard-Dose Penicillin V in the Treatment of Group a Streptococcal Pharyngitis in Children

Gary D. Williams, MD

Carla Saracusa, RN

Division of Pediatrics and Adolescent Medicine, Cleveland Clinic Children's Hospital, Cleveland, Ohio

Sharon V. Medendorp, MPH

Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation, Cleveland, Ohio

Camille Sabella, MD

John B. Lampe, MD

Richard E. Garcia, MD

Lisette Lebrun, MD

Division of Pediatrics and Adolescent Medicine, Cleveland Clinic Children's Hospital, Cleveland, Ohio

Johanna Goldfarb, MD

Department of Pediatrics-Desk A-120, Cleveland Clinic Children's Hospital, 9500 Euclid Avenue, Cleveland, Ohio 44195

A 10-day course of amoxicillin at a dosage of 40 mg per kilogram per day was compared with conventional (lower dosage) penicillin V therapy in the treatment of culture-proven Group A streptococcal pharyngitis in children 3 to 18 years of age in a prospective, randomized, and singleblinded study. Children had to have signs and symptoms compatible with the diagnosis of streptococcal pharyngitis and to have a throat swab positive for Group A streptococci. A second throat culture was obtained 10 to 14 days after the completion of therapy. Serotyping was performed to help differentiate carrier states from reinfections. Of 161 children enrolled, 113 were evaluable; 55 received penicillin and 58 received amoxicillin. At the completion of therapy 70.9% (39/55) of patients in the penicillin group vs 87.9% (51/58) of patients in the amoxicillin group were asymptomatic (clinical cure, P=0.025). At the completion of therapy, 54.5% (30/55) of patients in the penicillin group vs 79.3% (46/58) of patients in the amoxicillin group had negative throat cultures (bacteriologic cure, P=0.005). The carrier rate (children who were well but who were still carrying the same serotype of Group A streptococcus) also differed betweent the groups: 13 (23.6%) in the penicillin group compared with six (10.3%) in the amoxicillin group. Amoxicillin at 40 mg/kg/day was significantly more effective than lower dosages of penicillin V for clinical and bacteriologic cure in the treatment of Group A streptococcal pharyngitis in children. The current perception that penicillin is declining in effectiveness may be due to inadequate dosing.

Clinical Pediatrics, Vol. 37, No. 6, 341-346 (1998)
DOI: 10.1177/000992289803700602


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. R. Casey, R. Kahn, D. Gmoser, E. Atlas, K. Urbani, S. Luber, H. Pellman, and M. E. Pichichero Frequency of Symptomatic Relapses of Group A {beta}-Hemolytic Streptococcal Tonsillopharyngitis in Children From 4 Pediatric Practices Following Penicillin, Amoxicillin, and Cephalosporin Antibiotic Treatment Clinical Pediatrics, July 1, 2008; 47(6): 549 - 554. [Abstract] [PDF]

				D R Lennon, E Farrell, D R Martin, and J M Stewart Once-daily amoxicillin versus twice-daily penicillin V in group A {beta}-haemolytic streptococcal pharyngitis Arch. Dis. Child., June 1, 2008; 93(6): 474 - 478. [Abstract] [Full Text] [PDF]

				M. E. Pichichero The Importance of Bacteriologic Eradication in the Treatment of Group A Streptococcal Tonsillopharyngitis Clinical Pediatrics, May 1, 2007; 46(4_suppl): 3S - 16S. [Abstract] [PDF]

				M. E. Pichichero Pathogen Shifts and Changing Cure Rates for Otitis Media and Tonsillopharyngitis Clinical Pediatrics, July 1, 2006; 45(6): 493 - 502. [Abstract] [PDF]

				M. C. G. Diaz, N. Symons, M. L. Ramundo, and N. C. Christopher Effect of a Standardized Pharyngitis Treatment Protocol on Use of Antibiotics in a Pediatric Emergency Department Arch Pediatr Adolesc Med, October 1, 2004; 158(10): 977 - 981. [Abstract] [Full Text] [PDF]

				A. J. Lan, J. M. Colford, and J. MD The Impact of Dosing Frequency on the Efficacy of 10-Day Penicillin or Amoxicillin Therapy for Streptococcal Tonsillopharyngitis: A Meta-analysis Pediatrics, February 1, 2000; 105(2): 19e - 19. [Abstract] [Full Text]